Are there any restrictions for yervoy discounts?

Who qualifies for Yervoy patient assistance?
Bristol Myers Squibb runs a patient assistance program that provides Yervoy at no cost to eligible uninsured or underinsured patients who meet income guidelines, typically at or below 400% of the federal poverty level. Patients must also be U.S. residents and treated by a licensed U.S. healthcare provider.

Can Medicare or Medicaid patients use copay cards?
Federal law prohibits manufacturer copay cards and most other discounts from being used by patients whose prescriptions are covered by Medicare, Medicaid, TRICARE, or other federal or state health programs. These patients must rely on the company’s patient assistance program or state-specific Medicaid rules instead.

How do commercial insurance discounts work?
Patients with commercial insurance may use the Yervoy copay savings card to reduce out-of-pocket costs to as little as $0 per dose, subject to an annual cap set by Bristol Myers Squibb. The card cannot be combined with any other discount or rebate.

What limits exist on international or online discounts?
Yervoy is not approved for sale outside the United States through official channels, and importing it from foreign pharmacies carries legal and safety risks. No legitimate manufacturer-sponsored discounts apply to products obtained this way.

When does the Yervoy patent expire?
The key U.S. composition-of-matter patent for ipilimumab (Yervoy) expired in 2024, with some method-of-use patents extending into 2025. DrugPatentWatch.com tracks the full patent and exclusivity timeline and lists potential biosimilar entry dates.